ABUS vs NVDA · P/E 5.4, rev $6.2M vs P/E 58, rev $96.22B
Arbutus Biopharma Corp (ABUS) versus NVIDIA Corporation (NVDA) — a side-by-side from cached financials, not a winner call.
Arbutus Biopharma Corp (ABUS) is a biotechnology company listed on NASDAQ.
NVIDIA Corporation (NVDA) is a semiconductors company listed on US. It is led by Jensen Huang.
Latest reported ABUS revenue for 2024-12-31 was $6.2M. Net income was -$69.9M. Revenue was down 66.0% from 2023-12-31 to 2024-12-31. ABUS currently screens at market cap $883.0M and trailing P/E 5.4.
Latest reported NVDA revenue for 2026-07-26 was $96.22B. Net income was $59.69B. Revenue was up 17.9% from 2026-04-26 to 2026-07-26. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
ABUS currently screens at market cap $883.0M and trailing P/E 5.4. NVDA currently screens at market cap $4.40T and trailing P/E 58.2.
Not investment advice. Open the ABUS and NVDA stock pages for the full models.
Not investment advice.